3 hours Arcturus Therapeutics’ (ARCT) Buy Rating Reiterated at HC Wainwright MarketBeat
HC Wainwright reissued a “buy” rating and issued a $63.00 target price on shares of Arcturus Therapeutics in a research note on Tuesday.
HC Wainwright reissued a “buy” rating and issued a $63.00 target price on shares of Arcturus Therapeutics in a research note on Tuesday.